A combination of glycosylated hemoglobin, impaired fasting glucose and waist circumference is effective in screening for individuals at risk for future type 2 diabetes

Archives of Gerontology and Geriatrics

Volumn 50, Issue 1, 2010, Pages 105-109

  Motta, Massimo ^a   Bennati, Ettore ^a   Cardillo, Elisabeth ^a   Ferlito, Laura ^a   Passamonte, Michela ^a   Vacante, Marco ^a   Malaguarnera, Mariano ^a  

^a UNIVERSITY OF CATANIA   (Italy)

Author keywords

Glucose metabolism in elderly; HbA1c; Type 2 diabetes mellitus; Waist circumference in elderly

Indexed keywords

GLUCOSE; GLYCOSYLATED HEMOGLOBIN;

AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; DIFFERENTIAL DIAGNOSIS; FOLLOW UP; GLUCOSE BLOOD LEVEL; HEMOGLOBIN BLOOD LEVEL; HUMAN; IMPAIRED GLUCOSE TOLERANCE; MAJOR CLINICAL STUDY; NON INSULIN DEPENDENT DIABETES MELLITUS; PATHOPHYSIOLOGY; PREDICTION; PRIORITY JOURNAL; RISK FACTOR; WAIST CIRCUMFERENCE;

AGED; AGED, 80 AND OVER; DIABETES MELLITUS, TYPE 2; FEMALE; GERIATRIC ASSESSMENT; GLUCOSE TOLERANCE TEST; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPOGLYCEMIA; INCIDENCE; ITALY; LONGITUDINAL STUDIES; MALE; MASS SCREENING; PROGNOSIS; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; SEX DISTRIBUTION; WAIST CIRCUMFERENCE;

EID: 70449623496     PISSN: 01674943     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.archger.2009.02.009     Document Type: Article

References (57)

1. Abdul-Ghani M.A., Tripathy D., and DeFronzo R.A. Contributions of beta-cell dysfunction and insulin resistance to the pathogenesis of impaired glucose tolerance and impaired fasting glucose. Diabetes Care 29 (2006) 1130-1139
2. ADA (American Diabetes Association). Clinical practice recommendations, standards of medical care for patients with diabetes mellitus. Diabetes Care 26 (2003) S33-S50
3. ADA (American Diabetes Association). Standards of medical care in diabetes. Diabetes Care 28 (2005) S4-S36
4. ADA (American Diabetes Association). Diagnosis and classification of diabetes mellitus. Diabetes Care 30 (2007) S42-S47
5. Adams R.J., Appleton S., Wilson D.H., Taylor A.W., Dal Grande E., Chittle-borough C., Gill T., and Ruffin R. Population comparison of two clinical approaches to the metabolic syndrome: implications of the new International Diabetes Federation consensus definition. Diabetes Care 28 (2005) 2777-2779
6. ADVANCE, 2008. The largest ever study of diabetes shows intensive glucose control reduces serious complications. San Francisco, USA.
7. The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 20 (1997) 1183-1197
8. UK Prospective Diabetes Study (UKPDS) Group, and Anonymous. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 352 (1998) 837-853
9. Balkau B., Deanfield J.E., Despres J.P., Bassand J.P., Fox K.A., Smith Jr. S.C., Barter P., Tan C.E., Van Gaal L., Wittchen H.U., Massien C., and Haffner S.M. International Day for the Evaluation of Abdominal Obesity (IDEA): a study of waist circumference, cardiovascular disease, and diabetes mellitus in 168,000 primary care patients in 63 countries. Circulation 116 (2007) 1942-1951
10. Bays H.E., Chapman R.H., Grandy S., and SHIELD Investigators' Group. The relationship of body mass index to diabetes mellitus, hypertension and dyslipidaemia: comparison of data from two national surveys. Int. J. Clin. Pract. 61 (2007) 737-747
11. Beckett N.S., Peters R., Fletcher A.E., Staessen J.A., Liu L., Dumitrascu D., Stoyanovsky V., Antikainen R.L., Nikitin Y., Anderson C., Belhani A., Forette F., Rajkumar C., Thijs L., Banya W., Bulpitt C.J., and HYVET Study Group. Treatment of hypertension in patients 80 years of age or older. N. Engl. J. Med. 358 (2008) 1887-1898
12. Buse J.B., Bigger J.T., Byington R.P., Cooper L.S., Cushman W.C., Friedewald W.T., Genuth S., Gerstein H.C., Ginsberg H.N., Goff, Grimm, Margolis K.L., Probstfield J.L., Simons-Morton D.G., Sullivan M.D., and (The ACCORD Study Group). Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial: design and methods. Am. J. Cardiol. 99 (2007) 21i-33i
13. Cauchi S., Meyre D., Dina C., Choquet H., Samson C., Gallina S., Balkau B., Charpentier G., Pattou F., Stetsyuk V., Scharfmann R., Staels B., Frühbeck G., and Froguel P. Transcription factor TCF7L2 genetic study in the French population: expression in human beta-cells and adipose tissue and strong association with type 2 diabetes. Diabetes 55 (2006) 2903-2908
14. Cauchi S., Vaxillaire M., Choquet H., Durand E., Duval A., Polak M., and Froguel P. No major contribution of TCF7L2 sequence variants to maturity onset of diabetes of the young (MODY) or neonatal diabetes mellitus in French white subjects. Diabetologia 50 (2007) 214-216
15. Chandak G.R., Janipalli C.S., Bhaskar S., Kulkarni S.R., Mohankrishna P., Hattersley A.T., Frayling T.M., and Yajnik C.S. Common variants in the TCF7L2 gene are strongly associated with type 2 diabetes mellitus in the Indian population. Diabetologia 50 (2007) 63-67
16. Chen K.T., Chen C.J., Gregg E.W., Williamson D.F., and Narayan K.M. High prevalence of impaired fasting glucose and type 2 diabetes mellitus in Penghu Islets, Taiwan: evidence of a rapidly emerging epidemic?. Diabetes Res. Clin. Pract. 44 (1999) 59-69
17. Coutinho M., Gerstein H.C., Wang Y., and Yusuf S. The relationship between glucose and incident cardiovascular events. A metaregression analysis of published data from 20 studies of 95,783 individuals followed for 12.4 years. Diabetes Care 22 (1999) 233-240
18. DECODE Study Group, European Diabetes Epidemiology Group. Is the current definition for diabetes relevant to mortality risk from all causes and cardiovascular and noncardiovascular diseases?. Diabetes Care 26 (2003) 688-696
19. Despres J.P., and Lemieux I. Abdominal obesity and metabolic syndrome. Nature 444 (2006) 881-887
20. Dunstan D.W., Zimmet P.Z., Welborn T.A., De Courten M.P., Cameron A.J., Sicree R.A., Dwyer T., Colagiuri S., Jolley D., Knuiman M., Atkins R., and Shaw J.E. The rising prevalence of diabetes and impaired glucose tolerance: the Australian Diabetes, Obesity and Lifestyle Study. Diabetes Care 25 (2002) 829-834
21. Florenz J.C., Jablonski K.A., Bayley N., Pollin T.I., De Bakker P.I., Shuldiner A.R., Knowler W.C., Nathan D.M., Altshuler D., and Diabetes Prevention Program Research Group. TCF7L2 polymorphisms and progression to diabetes in the Diabetes Prevention Program. N. Engl. J. Med. 355 (2006) 241-250
22. Grant S.F., Thorleifsson G., Reynisdottir I., Benediktsson R., Manolescu A., Sainz J., Helgason A., Stefansson H., Emilsson V., Helgadottir A., Styrkarsdottir U., Magnusson K.P., Walters G.B., Palsdottir E., Jonsdottir T., Gudmundsdottir T., Gylfason A., Saemundsdottir J., Wilensky R.L., Reilly M.P., Rader D.J., Bagger Y., Christiansen C., Gudnason V., Sigurdsson G., Thorsteinsdottir U., Gulcher J.R., Kong A., and Stefansson K. Variant of transcription factor 7-like 2 (TCF7L2) gene confers risk of type 2 diabetes. Nat. Genet. 38 (2006) 320-323
23. Humphries S.E., Gable D., Cooper J.A., Ireand H., Stephens J.W., Huresl S.J., Li K.W., Palmen J., Miller M.A., Cappuccio F.P., Elkeles R., Godsland I., Miller G.J., and Talmud P.J. Common variants in the TCF7L2 gene and predisposition to type 2 diabetes in UK European Whites, Indian Asians and Afro-Caribbean men and women. J. Mol. Med. 84 (2006) 1005-1014
24. IDF (International Diabetes Federation), 2005. Consensus worldwide definition of the metabolic syndrome. .
25. ILSA (Longitudinal Study on Aging) Working Group. Prevalence of chronic diseases in older Italians: comparing self reported and clinical diagnosis. Int. J. Epidemiol. 26 (1997) 995-1002
26. Ko G.T., Chan J.C., Chow C.C., Yeung V.T., Chan W.B., So W.Y., and Cockram C.S. Effects of obesity on the conversion from normal glucose tolerance to diabetes in Hong Kong Chinese. Obes. Res. 12 (2004) 889-895
27. Kosaka K., Noda M., and Kuzuya T. Prevention of type 2 diabetes by lifestyle intervention: a Japanese trial in IGT males. Diabetes Res. Clin. Pract. 67 (2005) 152-162
28. Lenti, G., Pellegrini, A., Pagano, G., 1970. Moderni aspetti fisiopatologici e clinici della malattia diabetica. 71° Congr. S.I.M.I. (in Italian).
29. Liao D., Shofer J.B., Boyko E.J., McNeely M.J., Leonetti D.L., Kahn S.E., and Fujimoto W.Y. Abnormal glucose tolerance and increased risk for cardiovascular disease in Japanese-Americans with normal fasting glucose. Diabetes Care 24 (2001) 39-44
30. Maggi, S., Romanato, G., 2008. Epidemiologia della sindrome metabolica nell'an-ziano. Sindr. Metab. Mal. Cardiovasc. 1, 22 (in Italian).
31. Maggi S., Zucchetto M., Grigoletto F., Baldereschi M., Candelise L., Scarpini E., Scarlato G., Amaducci L., and for the ILSA Group. The Italian Longitudinal Study on Aging (ILSA): design and methods. Aging Clin. Exp. Res. 6 (1994) 464-473
32. Motta, L., Carnazzo, G., 1994. Il diabete nell'anziano, 95° Congr. S.I.M.I. Florence.
33. Motta M., Bennati E., Ferlito L., and Malaguarnera M. Diabetes mellitus in the elderly: diagnostic features. Arch. Gerontol. Geriatr. 42 (2006) 101-106
34. Motta, M., Bennati, E., Cardillo, E., Passamonte, M., Ferlito, L., Malaguarnera, M., 2008a. The metabolic syndrome (MS) in the elderly: Considerations on the diagnostic criteria of the International Diabetes Federation (IDF) and some proposed modifications. Arch. Gerontol. Geriatr. doi:10.1016/j.archger.-2008.03.005.
35. Motta M., Bennati E., Cardillo E., and Malaguarnera M. Pathogenesis of the senile diabetes. Indian J. Med. Res. 128 (2008) 225-227
36. Motta, M., Bennati, E., Cardillo, E., Ferlito, L., Malaguarnera, M., 2009. The value glycosylated hemoglobin (HbA1c) as a predictive risk factor in the diagnosis of diabetes mellitus (DM) in the elderly. Arch. Gerontol. Geriatr. Apr 1 [Epub ahead of print].
37. National Heart, Lung, and Blood Institute, 2008. ACCORD telebriefing prepared remarks, February 6.
38. Norberg M., Eriksson J.W., Lindahl B., Andersson C., Rolandsson O., Stenlund H., and Weinehall L. A combination of HbA1c, fasting glucose and BMI is effective in screening for individuals at risk of future type2 diabetes: OGTT is not needed. J. Intern. Med. 260 (2006) 263-271
39. Ramachandran A., Snehalatha C., Mary S., Mukesh B., Bhaskar A.D., Vijay V., and Indian Diabetes Prevention Programme (IDPP). The Indian Diabetes Prevention Programme shows that lifestyle modification and metformin prevent type 2 diabetes in Asian Indian subiects with impaired glucose tolerance (IDPP-1). Diabetologia 49 (2006) 289-297
40. Sargeant L.A., Bennett F.I., Forrester T.E., Cooper R.S., and Wilks R.J. Predicting incident diabetes in Jamaica: the role of anthropometry. Obes. Res. 10 (2002) 792-798
41. Satman I., Yilmaz T., Sengül A., Salman S., Salman F., Uygur S., Bastar I., Tütüncü Y., Sargin M., Dinççag N., Karsidag K., Kalaça S., Ozcan C., and King H. Population-based study of diabetes and risk characteristics in Turkey: results of the Turkish Diabetes Epidemiology Study (TURDEP). Diabetes Care 25 (2002) 1551-1556
42. Saxena R., Gianniny L., Burt L.P., Lyssenko V., Giuducci C., Sjögren M., Florez J.C., Almgren P., Isomaa B., Orho-Melander M., Lindblad U., Daly M.J., Tuomi T., Hirschhorn J.N., Ardlie K.G., Groop L.C., and Altshuler D. Common single nucleotide polymorphisms in TCF7L2 are reproducibly associated with type 2 diabetes and reduce the insulin response to glucose in nondiabetic individuals. Diabetes 55 (2006) 2890-2895
43. Schmidt M.I., Duncan B.B., Bang H., Pankow J.S., Ballantyne C.M., Golden S.H., Folsom A.R., Chambless L.E., and the ARIC Investigators. Identifying individuals at high risk for diabetes: the Atherosclerosis Risk in Communities study. Diabetes Care 28 (2005) 2013-2018
44. Schulze M.B., Heidemann C., Schienkiewitz A., Bergmann M.M., Hoffmann K., and Boeing H. Comparison of anthropometric characteristics in predicting the incidence of type 2 diabetes in the EPIC-Potsdam study. Diabetes Care 29 (2006) 1921-1923
45. Shaw J.E., Zimmet P.Z., De Courten M., Dowse G.K., Chitson P., Gareeboo H., Hemraj F., Fareed D., Tuomilehto J., and Alberti K.G. Impaired fasting glucose or impaired glucose tolerance. what best predicts future diabetes in Mauritius?. Diabetes Care 22 (1999) 399-402
46. Smith, Allen J., Blair S.N., Bonow R.O., Brass L.M., Fonarow G.C., Grundy S.M., Hiratzka L., Jones D., Krumholz H.M., Mosca L., Pasternak R.C., Pearson T., Pfeffer M.A., Taubert K.A., AHA/ACC; National Heart, Lung, and and Blood Institute. AHA/ACC guidelines for secondary prevention for patients with coronary and other atherosclerotic vascular disease: 2006 update: endorsed by the National Heart, Lung, and Blood Institute. Circulation 113 (2006) 2363-2372
47. Thorwaldsen P., Asplund K., Kuulasmaa K., Rajakangas A.M., and Schroll M. Stroke incidence, case fatality, and mortality in the WHO MONICA project. World Health Organization Monitoring Trends and Determinants in Cardio-vascular Disease. Stroke 26 (1995) 361-367
48. Tulloch-Reid M.K., Williams D.E., Looker H.C., Hanson R.L., and Knowler W.C. Do measures of body fat distribution provide information on the risk of type 2 diabetes in addition to measures of general obesity? Comparison of anthropometric predictors of type 2 diabetes in Pima Indians. Diabetes Care 26 (2003) 2556-2561
49. Tuomilehto J., Lindström J., Eriksson J.G., Valle T.T., Hämäläinen H., Ilanne-Parikka P., Keinänen-Kiukaanniemi S., Laakso M., Louheranta A., Rastas M., Salminen V., Uusitupa M., and Finnish Diabetes Prevention Study Group. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N. Engl. J. Med. 344 (2001) 1343-1350
50. Twigg S.M., Kamp M.C., Davis T.M., Nejlon E.K., Flack J.R., and Australian Diabetes Society; Australian Diabetes Educators Association. Prediabetes: a position statement from the Australian Diabetes Society and Australian Diabetes Educators Association. Med. J. Aust. 186 (2007) 461-465
51. US Department of Health and Human Services, 2002. American Diabetes Association. HHS, ADA warns Americans of "pre-diabetes". Press release. DHHS, Washington, DC.
52. Vaccaro O., and Riccardi G. Changing the definition of impaired fasting glucose: impact on the classification of individuals and risk definition. Diabetes Care 28 (2005) 1786-1788
53. WHO (World Health Organization). Report of a WHO Consultation, Definition, Diagnosis and Classification of Diabetes Mellitus and Its Complications, Part 1: Diagnosis and Classification of Diabetes Mellitus (1999), WHO, Department of Non Communicable Disease Surveillance, Geneva
54. Wood D., De Backer G., Faergeman O., Graham I., Mancia G., and Pyörälä K. Prevention of coronary heart disease in clinical practice: recommendations of the Second Joint Task Force of European and other Societies on Coronary Prevention. Atherosclerosis 140 (1998) 199-270
55. Zeggini E., and McCarthy M.I. TCF7L2: the biggest story in diabetes genetics since HLA?. Diabetologia 50 (2007) 1-4
56. Zeggini E., Scott L.J., Saxena R., Voight B.F., Marchini J.L., Hu T., De Bakker P.I., Becasis G.R., Almgren P., Andersen G., Ardlie K., Boström K.B., Bergman R.N., Bonnycastle L.L., Borch-Johnsen K., Burtt N.P., Chen H., Chines P.S., Daly M.J., Deodhar P., Ding C.J., Doney A.S., Duren W.L., Elliott K.S., Erdos M.R., Frayling T.M., Freathy R.M., Gianniny L., Grallert H., Grarup N., Groves C.J., Guiducci C., Hansen T., Herder C., Hitman G.A., Hughes T.E., Isomaa B., Jackson A.U., Jørgensen T., Kong A., Kubalanza K., Kuruvilla F.G., Kuusisto J., Langenberg C., Lango H., Lauritzen T., Li Y., Lindgren C.M., Lyssenko V., Marvelle A.F., Meisinger C., Midthjell K., Mohlke K.L., Morken M.A., Morris A.D., Narisu N., Nilsson P., Owen K.R., Palmer C.N., Payne F., Perry J.R., Pettersen E., Platou C., Prokopenko I., Qi L., Qin L., Rayner N.W., Rees M., Roix J.J., Sandbæk A., Shields B., Sjögren M., Steinthorsdottir V., Stringham H.M., Swift A.J., Thorleifsson G., Thorsteinsdottir U., Timpson N.J., Tuomi T., Tuomilehto J., Walker M., Watanabe R.M., Weedon M.N., Willer C.J., Wellcome Trust Case Control Consortium, Illig T., Hveem K., Hu F.B., Laakso M., Stefansson K., Pedersen O., Wareham N.J., Barroso I., Hattersley A.T., Collins F.S., Groop L., McCarthy M.I., Boehnke M., and Altshuler D. Meta-analysis of genome-wide association data and large-scale replication identifies additional susceptibility loci for type 2 diabetes. Nat. Genet. 40 (2008) 638-645
57. Zhang C., Qi L., Hunter D.J., Meigs J.B., Manson J.E., Van Dam R.M., and Hu F.B. Variant of transcription factor 7-like 2 (TCF7L2) gene and the risk of type 2 diabetes in large cohorts of U:S. women and men. Diabetes 55 (2006) 2645-2648